| Type (acronym) | rmp |
|---|---|
| Type | reference measurement procedure |
| Unique Nomination Number | C20RMP4 |
| Analyte Name | aldosterone |
| Method capable of Traceability of Analyte to SI or Defined Procedure | SI
|
| Applicable Matrices | human plasma; fresh, frozen or lyophilized |
| Name | GPHCM reference measurement method/procedure for aldosterone in human plasma |
| Organization that developed Validated Method | Guangdong Provincial Hospital of Chinese Medicine (GPHCM) |
| Measurement Techniques Used | Isotope dilution liquid chromatography mass spectrometry |
| Quantity | Amount-of-substance concentration |
| From (0) | 0.0277 |
| To (0) | 2.7744 |
| Unit (0) | nmol/L |
| From (1) | 0.009 |
| To (1) | 0.039 |
| Unit (1) | nmol/L |
| Level of Confidence (%) | 95% |
| Peer Reviewed Publication | An isotope dilution liquid chromatography-tandem mass spectrometry candidate reference measurement procedure for aldosterone measurement in human plasma. Zhuang J. et al, Analytical and Bioanalytical Chemistry 2021 413 4471-4481 |
| Hyperlink to Final Report of extent of Equivalence Studies among | C20RMP4 Extent-of-equivalence report for CGPHM RMP ALD.pdf |
| Analyte Category Name | Non-peptide hormones |
| Non-CCQM Key Comparison Report | C20 RMP4 Interlaboratory comparison report for ALD RMP |
| Non-CCQM Key Comparison Report Hyperlink | https://www.jctlmdb.org/backend/api/jctlmFile/downloadFile/825/16 |
| Measurement principle/technique | Isotope dilution mass spectrometry |
| Measurement principle/technique | Liquid chromatography mass spectrometry |